Zelluna Immunotherapy closed a funding round (amount undisclosed) in Aug 2022. The company is based in Oslo, Norway. Investors in the round: Takeda Ventures. Data as of Nov 2026.
Amount raised
—
undisclosed
Native amount
—
Stage
Other
funding round
Investors
1
Provenance & confidence
UnverifiedAmount
Amount undisclosed or unconverted.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Other rounds
same companyRelated news
- Zelluna Immunotherapy Receives Investment from Takeda Venturesfinsmes.com · 2022-08